We are live on ! Find out more
Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $481B
1-Year Est. Return 30.42%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+30.42%
3 Year Est. Return
+88.16%
5 Year Est. Return
+120.13%
10 Year Est. Return
+468.8%
AUM
$134B
AUM Growth
+$5.5B
Cap. Flow
+$3.82B
Cap. Flow %
2.85%
Top 10 Hldgs %
8.43%
Holding
3,643
New
102
Increased
2,063
Reduced
953
Closed
48

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$344M
2
INTC icon
Intel
INTC
+$219M
3
AAPL icon
Apple
AAPL
+$206M
4
PFE icon
Pfizer
PFE
+$201M
5
JPM icon
JPMorgan Chase
JPM
+$178M

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$173M
2
BAC icon
Bank of America
BAC
+$171M
3
C icon
Citigroup
C
+$111M
4
VPHM
VIROPHARMA INC
VPHM
+$103M
5
LEAP
LEAP WIRELESS INTERNATIONAL INC NEW
LEAP
+$48.6M

Sector Composition

Rank Sector Weight
1 Financials 18.88%
2 Industrials 13.29%
3 Energy 11.48%
4 Technology 10.2%
5 Healthcare 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRPH
3226
DELISTED
ProPhase Labs
PRPH
$386K ﹤0.01%
19,298
-2
-0% -$38
GEVA
3227
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$385K ﹤0.01%
4,645
+3,859
+491% +$357K
SGB
3228
DELISTED
Southwest Georgia Financial Corporation
SGB
$385K ﹤0.01%
29,007
– –
NBN icon
3229
Northeast Bank
NBN
$1.06B
$384K ﹤0.01%
41,021
– –
ATE
3230
DELISTED
Advantest Corp
ATE
$374K ﹤0.01%
34,596
-100
-0.3% -$1.09K
QCRH icon
3231
QCR Holdings
QCRH
$1.69B
$370K ﹤0.01%
21,535
+5,552
+35% +$95.3K
MPB icon
3232
Mid Penn Bancorp
MPB
$971M
$369K ﹤0.01%
24,917
– –
BSDM
3233
DELISTED
BSD MEDICAL CORP (DEL)
BSDM
$369K ﹤0.01%
286,126
-295
-0.1% -$366
JMBA
3234
DELISTED
Jamba, Inc.
JMBA
$364K ﹤0.01%
+30,308
New +$379K
MEOH icon
3235
Methanex
MEOH
$4.3B
$358K ﹤0.01%
5,595
-35,500
-86% -$2.24M
MPO
3236
DELISTED
MIDSTATES PETE CO INC COM NEW
MPO
$358K ﹤0.01%
+6,685
New +$350K
MXC icon
3237
Mexco Energy
MXC
$17.8M
$351K ﹤0.01%
45,479
– –
STRM
3238
DELISTED
Streamline Health Solutions
STRM
$349K ﹤0.01%
4,623
– –
FWV
3239
DELISTED
FIRST WEST VIRGINIA BANCRP INC
FWV
$347K ﹤0.01%
17,901
– –
DRL
3240
DELISTED
DORAL FINANCIAL CORPORATION (NEW)
DRL
$346K ﹤0.01%
39,902
-4,267
-10% -$53.6K
RDIB
3241
Reading International Class B
RDIB
$345K ﹤0.01%
38,048
– –
GIL icon
3242
Gildan
GIL
$10.3B
$338K ﹤0.01%
13,400
– –
EDUC icon
3243
Educational Development Corp
EDUC
$11.8M
$337K ﹤0.01%
181,566
– –
TSRI
3244
DELISTED
TSR Inc. New
TSRI
$335K ﹤0.01%
99,667
– –
LMNR icon
3245
Limoneira
LMNR
$235M
$334K ﹤0.01%
14,707
+4,800
+48% +$108K
INO icon
3246
Inovio Pharmaceuticals
INO
$55.7M
$325K ﹤0.01%
2,034
– –
HWG
3247
DELISTED
HALLWOOD GROUP INC(THE)
HWG
$319K ﹤0.01%
25,814
– –
CNH
3248
CNH Industrial
CNH
$12.7B
$318K ﹤0.01%
32,082
-433,017
-93% -$4.16M
MSTR icon
3249
Strategy Inc
MSTR
$34.1B
$316K ﹤0.01%
27,400
+26,400
+2,640% +$330K
RBPAA
3250
DELISTED
Royal Bancshares Of Pennsylvania Inc
RBPAA
$316K ﹤0.01%
95,767
– –
128 129
130
131 132

Similar funds

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Dimensional Fund Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Dimensional Fund Advisors held 3,643 positions worth $134B, up 4.3% from $128B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Trading was light in Q1 2014: portfolio turnover was 4.1%. Dimensional Fund Advisors opened 102 new positions and exited 48, leaving the 3,643-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Energy.

  • Dimensional Fund Advisors's largest Q1 2014 buy was SIZMEK INC COM STK (DE): 1,323,230 shares worth $14.1M.
  • Dimensional Fund Advisors added most to ExxonMobil in Q1 2014, an estimated $344M increase.
  • Dimensional Fund Advisors's biggest Q1 2014 reduction was Vodafone, cutting an estimated $173M.
  • Dimensional Fund Advisors fully exited VIROPHARMA INC in Q1 2014, selling an estimated $103M.
  • Dimensional Fund Advisors's ten largest holdings make up 8.4% of its $134B portfolio in Q1 2014.
  • Dimensional Fund Advisors opened 102 new positions and closed 48 in Q1 2014.
  • Dimensional Fund Advisors's portfolio value rose 4.3% quarter-over-quarter to $134B.

Based on Dimensional Fund Advisors's 13F filing for Q1 2014, filed 14 May 2014.